Catharine I. Paules

Penn State Milton S. Hershey Medical Center

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 15 papers. Top paper: “Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19”.

Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19

New England Journal of Medicine(2020)10.1056/nejmoa2031994

N/A

6.8DataRank · unranked

1924 citations

Thomas F. Patterson, Aneesh K. Mehta, Kay M Tomashek, Cameron R. Wolfe, Varduhi Ghazaryan +55 more

Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial

The Lancet Respiratory Medicine(2022)10.1016/s2213-2600(22)00088-1

N/A

3.0DataRank · unranked

128 citations

Kay M Tomashek, Thomas F. Patterson, Carlos A. Gómez, Vincent C. Marconi, Mamta K. Jain +95 more

SARS-CoV-2 RNA and Nucleocapsid Antigen Are Blood Biomarkers Associated With Severe Disease Outcomes That Improve in Response to Remdesivir

The Journal of Infectious Diseases(2024)10.1093/infdis/jiae198

N/A

0.439DataRank · unranked

13 citations

Kevin Rubenstein, Viviane Callier, Katy Shaw-Saliba, Adam Rupert, Robin Dewar +94 more

Temporal Improvements in COVID-19 Outcomes for Hospitalized Adults: A Post Hoc Observational Study of Remdesivir Group Participants in the Adaptive COVID-19 Treatment Trial

Annals of Internal Medicine(2022)10.7326/m22-2116

N/A

0.434DataRank · unranked

6 citations

Tyler Bonnett, Kevin Rubenstein, David A Lindholm, Rekha R. Rapaka, Sarah B. Doernberg +39 more

A Risk Profile Using Simple Hematologic Parameters to Assess Benefits From Baricitinib in Patients Hospitalized With COVID-19: A Post Hoc Analysis of the Adaptive COVID-19 Treatment Trial-2

Annals of Internal Medicine(2024)10.7326/m23-2593

N/A

0.376DataRank · unranked

6 citations

Jing Wang, Kay M. Tomashek, Tyler Bonnett, Kanal Singh, Vincent C. Marconi +16 more

Blood absolute lymphocyte count and trajectory are important in understanding severe COVID-19

BMC Infectious Diseases(2025)10.1186/s12879-024-10428-7

N/A

0.330DataRank · unranked

8 citations

Jacqueline Nordwall, Kathryn Shaw‐Saliba, Judith A. Aberg, Edward M. Gardner, Anna L. Goodman +8 more

Underuse of SARS-CoV-2–Neutralizing Monoclonal Antibodies in Skilled Nursing Facilities

Journal of the American Medical Directors Association(2023)10.1016/j.jamda.2023.10.003

N/A

0DataRank · unranked

0 citations

Nicole Osevala, Erik Lehman, Emily S. Heilbrunn, Erica Francis, Ruth Hogentogler +3 more

Respiratory and Other Infections Following COVID

PEDIATRICS(2025)10.1542/peds.2024-068280

N/A

0DataRank · unranked

1 citations

Nhat Minh Nguyen, Vitaly Lorman, Mitchell Maltenfort, Abu Saleh Mohammad Mosa, Anisha Sekar +20 more

Vaccine Effectiveness Among 5- to 17-year-old Individuals with Prior SARS-CoV-2 Infection: An EHR-Based Target Trial Emulation Study from the RECOVER Project

medRxiv(2025)10.1101/2025.02.07.25321814

N/A

0DataRank · unranked

1 citations

Yuqing Lei, Qiong Wu, Ting Zhou, Bingyu Zhang, Michael J. Becich +30 more

Vaccine Effectiveness Among 5- to 17-year-old Individuals with Prior SARS-CoV-2 Infection: An EHR-Based Target Trial Emulation Study from the RECOVER Project

Research Square(2025)10.21203/rs.3.rs-6945998/v1

N/A

0DataRank · unranked

1 citations

Yuqing Lei, Jiajie Chen, Qiong Wu, Ting Zhou, Bingyu Zhang +30 more

COVID-19: The therapeutic landscape

Med(2021)10.1016/j.medj.2021.04.015

N/A

0DataRank · unranked

25 citations

Anthony S. Fauci, Catharine I. Paules

Remdesivir for the Prevention of Invasive Mechanical Ventilation or Death in Coronavirus Disease 2019 (COVID-19): A Post Hoc Analysis of the Adaptive COVID-19 Treatment Trial-1 Cohort Data

Clinical Infectious Diseases(2021)10.1093/cid/ciab695

N/A

0DataRank · unranked

17 citations

Shannon Gallagher, Rekha R. Rapaka, Richard T. Davey, Sarah B. Doernberg, Robert Grossberg +11 more

Accelerating guideline dissemination in nursing homes during the COVID-19 pandemic: A patient-centered randomized controlled trial

Geriatric Nursing(2023)10.1016/j.gerinurse.2023.04.013

N/A

0DataRank · unranked

8 citations

Emily S. Heilbrunn, William A. Calo, Lan Kong, Erik Lehman, Ellie Hogentogler +10 more

Mpox Knowledge and Vaccine Willingness Among a Representative Analysis of Adults in Pennsylvania

Infectious Diseases in Clinical Practice(2023)10.1097/ipc.0000000000001303

N/A

0DataRank · unranked

7 citations

Kathryn Risher, William A. Calo, Jennifer L. Kraschnewski, Emily S. Heilbrunn, Catharine I. Paules +1 more

Evaluating Demographic Representation in Clinical Trials: Use of the Adaptive Coronavirus Disease 2019 Treatment Trial (ACTT) as a Test Case

Open Forum Infectious Diseases(2023)10.1093/ofid/ofad290

N/A

0DataRank · unranked

2 citations

Noreen A. Hynes, Corri B. Levine, Katherine Yang, Zanthia Wiley, Nikolaus Jilg +37 more